Who And Partners Launch New Online Resource To Advance Sti Vaccine Development

The First Online Portal On Vaccine Development For Sexually Transmitted Infections (Stis) Was Launched At The 23Rd Iusti World Congress. The Portal, Sti Watch Contains Technically Sound And Updated Information On The Most Common Stis And The Vaccine Development Status For Each.Despite Decades Of Global Efforts To Control Stis, Which Have A Major Impact On Sexual And Reproductive Health, By Promoting Healthier Sexual Behaviours, Including Increasing Condom Use, Treating People With Sti Symptoms, And Improving Access To Testing And Treatment, Global Sti Rates Remain Stubbornly High. Innovations Are Needed In The Fight Against Stis. The Development Of Safe And Effective Sti Vaccines Has The Potential To Revolutionize The Approach To Sti Prevention.Sti Watch Is A Collaborative Effort Between Who, Us National Institute Of Allergy And Infectious Diseases (Niaid) And Aids Vaccine Advocacy Coalition (Avac). Who And Niaid Along With Other Key Stakeholders Have Developed A Roadmap For Sti Vaccine Development And Introduction. The Roadmap Lays Out Next Steps For Accelerating Sti Vaccine Development, Including: Assessing The Public Health Need And Value Of New Vaccines; Defining Their Preferred Product Characteristics; And Outlining The Pathway To Developing, Evaluating And Licensing The Vaccines.This Collaboration Was Extended To Avac To Create A Web-Based Clearinghouse For Sti Vaccines In Order To Raise Their Profile Globally.Most Stis Go Untreated, Often Because They Cause No Symptoms. If Left Untreated, Stis Are Easily Transmitted To Others, And Can Cause Severe Health Consequences, Including Increased Risk For Hiv, Infertility, Adverse Pregnancy Outcomes And Cancer. Vaccines Currently Exist For Only 2 Common Stis

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!